TH79958B - The use of a cyclopropane derivative, which has been replaced to produce drugs for the treatment of metabolic syndrome. - Google Patents
The use of a cyclopropane derivative, which has been replaced to produce drugs for the treatment of metabolic syndrome.Info
- Publication number
- TH79958B TH79958B TH501005797A TH0501005797A TH79958B TH 79958 B TH79958 B TH 79958B TH 501005797 A TH501005797 A TH 501005797A TH 0501005797 A TH0501005797 A TH 0501005797A TH 79958 B TH79958 B TH 79958B
- Authority
- TH
- Thailand
- Prior art keywords
- treatment
- metabolic syndrome
- replaced
- alkyl
- produce drugs
- Prior art date
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drugs Drugs 0.000 title abstract 3
- 125000001559 cyclopropyl group Chemical class [H]C1([H])C([H])([H])C1([H])* 0.000 title abstract 2
- 239000000126 substance Substances 0.000 claims abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 201000002674 obstructive nephropathy Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
Abstract
การใช้อนุพันธ์กรดไซโคลโพรเพนซึ่งถูกแทนที่และเกลือซึ่งทนได้ทางสรีรวิทยาของสาร ดังกล่าวเพื่อผลิตยาสำหรับรักษากลุ่มอาการเมแทบอลิก การใช้สารประกอบตามสูตร I (สูตรเคมี) I โดยที่อนุมูลมีความหมายดังระบุ และเกลือซึ่งทนได้ทางสรีรวิทยาของสารดังกล่าว เพื่อผลิตยาสำหรับ รักษากลุ่มอาการเมแทบอลิก The use of a displaced cyclopropane derivative and physiologically resistant salt of the substance. To produce drugs for the treatment of metabolic syndrome. The use of compounds according to formula I (chemical formula) I, where radicals have the following meaning. And the physiologically tolerable salts of such substances To produce drugs for Treatment of metabolic syndrome
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH79958B true TH79958B (en) | 2006-09-14 |
| TH79958A TH79958A (en) | 2006-09-14 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS53688B1 (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
| RS52823B (en) | Novel compounds useful for the treatment of degenerative and inflammatory diseases. | |
| EA200901563A1 (en) | NEW METHOD OF SYNTHESIS OF IVABRADIN AND ITS SALTS OF CONNECTION WITH PHARMACEUTICALLY ACCESSIBLE | |
| RS53142B (en) | Compounds having crth2 antagonist activity | |
| EA200901609A1 (en) | AMIDES OF PYRAZOLKARBONIC ACID APPLICABLE AS MICROBIOCIDES | |
| EA201001669A1 (en) | SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281 | |
| EA201001455A1 (en) | Pyridine and pyrazine as PI3K inhibitors (phosphatidylinositin kinase-3) | |
| ATE440833T1 (en) | ANTITHRBOTIC DIAMIDES | |
| EA200900707A1 (en) | A NEW METHOD OF SYNTHESIS OF 7,8-DIMETOXY-1,3-DIHYDRO-2H-3-BENZAZEPIN-2-SHE, AND ITS APPLICATION IN THE SYNTHESIS OF IVABRADIN AND ITS SALTS OF CONNECTION WITH PHARMACEUTICAL SUBSTITUTION | |
| NO20076396L (en) | Substituted acrylamide derivative and pharmaceutical composition comprising this | |
| TH79958B (en) | The use of a cyclopropane derivative, which has been replaced to produce drugs for the treatment of metabolic syndrome. | |
| TH79958A (en) | The use of a cyclopropane derivative, which was replaced to produce drugs for the treatment of metabolic syndrome. | |
| AR074592A1 (en) | CRYSTALLINE FORMS OF A 3-CARBOXIPROPIL-AMINOTETRALINE COMPOUND, PROCESSES AND INTERMEDIARY FOR THEIR SYNTHESIS AND ITS USE IN THE TREATMENT OF A DISEASE MEDIATED BY AN ANTIGONIST OF MU OPIOID RECEPTORS. | |
| EA201001270A1 (en) | A NEW METHOD OF OBTAINING SULPHONYPLYROLES AS HISTONDEZETYLASE INHIBITORS (HDAC) | |
| RS53896B1 (en) | Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases | |
| EA201070274A1 (en) | TRICYCLIC AMINE COMPOUND | |
| AR052865A1 (en) | PREPARATION OF PHARMACEUTICAL COMPOUNDS DERIVED FROM SALES OF PIPERAZINA | |
| TH98902A (en) | The use of substitutated pyranone acid derivatives for the manufacture of drugs for the treatment of metabolic syndrome. | |
| TH98902B (en) | The use of substitutated pyranone acid derivatives for the manufacture of drugs for the treatment of metabolic syndrome. | |
| EA201300601A1 (en) | NEW MULTICOMPONENT CRYSTALS FROM ETHYL ETHER | |
| TH67535A (en) | Kyrenoxazole-aryl propionic acid derivative And the use of this substance as PPAR agonist | |
| TH69682A (en) | Therapeutic agents | |
| WO2008102037A8 (en) | Use of compounds as inhibitors for helicobacter flavodoxin | |
| TH124147B (en) | 1,2,5-Oxadiazoles (1,2,5- Oxadiazoles) as inhibitors of indoleamines. 2,3-Dioxygenase (Indoleamine 2,3 - Dioxygenase) | |
| TH104948A (en) | Therapeutic agents - 802. |